165
Participants
Start Date
November 30, 2006
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
ABT-751
200 mg ABT-751 daily for 14 days every 21 days
pemetrexed
Standard pemetrexed every 21 days
placebo
Placebo daily for 14 days every 21 days
Site Reference ID/Investigator# 3333, Miskolc
Site Reference ID/Investigator# 3332, Székesfehérvár
Site Reference ID/Investigator# 5098, Lake Success
Site Reference ID/Investigator# 3354, Bethelem
Site Reference ID/Investigator# 6006, Philadelphia
Site Reference ID/Investigator# 2401, Bethesda
Site Reference ID/Investigator# 2416, Baltimore
Site Reference ID/Investigator# 2242, Huntersville
Site Reference ID/Investigator# 3807, Atlanta
Site Reference ID/Investigator# 2411, Fort Lauderdale
Site Reference ID/Investigator# 3363, Lakeland
Site Reference ID/Investigator# 3352, Port Saint Lucie
Site Reference ID/Investigator# 2414, Bristol
Site Reference ID/Investigator# 2413, Columbus
Site Reference ID/Investigator# 3359, Indianapolis
Site Reference ID/Investigator# 2075, Kalamazoo
Site Reference ID/Investigator# 3403, Thessaloniki
Site Reference ID/Investigator# 3406, Thessaloniki
Site Reference ID/Investigator# 3353, Chicago
Site Reference ID/Investigator# 4687, Brno
Site Reference ID/Investigator# 2418, Jefferson City
Site Reference ID/Investigator# 4278, Kyjov
Site Reference ID/Investigator# 3405, Heraklion
Site Reference ID/Investigator# 4102, Hot Springs
Site Reference ID/Investigator# 3358, Fayetteville
Site Reference ID/Investigator# 2417, Fort Collins
Site Reference ID/Investigator# 2127, Greenbrae
Site Reference ID/Investigator# 2070, Tacoma
Site Reference ID/Investigator# 5690, Torrington
Site Reference ID/Investigator# 2244, Baltimore
Site Reference ID/Investigator# 3793, Peabody
Site Reference ID/Investigator# 3362, Worcester
Site Reference ID/Investigator# 4170, St Louis
Site Reference ID/Investigator# 3357, Lebanon
Site Reference ID/Investigator# 3337, Brno
Site Reference ID/Investigator# 3328, Nový Jičín
Site Reference ID/Investigator# 3327, Olomouc
Site Reference ID/Investigator# 3343, Ostrava-Poruba
Site Reference ID/Investigator# 3344, Prague
Site Reference ID/Investigator# 3342, Prague
Site Reference ID/Investigator# 3411, Příbram
Site Reference ID/Investigator# 3331, Budapest
Site Reference ID/Investigator# 3409, Amsterdam
Site Reference ID/Investigator# 3319, Eindhoven
Site Reference ID/Investigator# 3341, Haraderwijk
Site Reference ID/Investigator# 3528, Hoorn
Site Reference ID/Investigator# 3400, Bratislava
Site Reference ID/Investigator# 3410, Martin
AbbVie (prior sponsor, Abbott)
INDUSTRY